Our oncology network

SMS-oncology provides easy access to Investigators

Early stage oncology clinical trials are instrumental for future market positioning of an anticancer agent. Identification and enrollment of the optimal oncology patient population is one the most infamous challenges. With extensive, combined oncology & clinical research experience, SMS-oncology staff has access to leading key oncologists, renowned clinical centers, and various specialized oncology research groups throughout Europe.

SMS-oncology leverages strong working relationships with a number of Early Phase units in the Benelux (9 phase I centers), the United Kingdom (7 phase I centers) and various other European countries like Spain, France, Switzerland, Denmark and Norway. Our office in Budapest Hungary serves as hub for CEE Trials.

Patient feasibilities studies

SMS-oncology executes carefully thought through feasibility studies in order to set the proper stage for larger, pivotal Phase II/III studies. Ensuring the correct assumptions are in place is a key success factor to building a reliable feasibility questionnaire which investigators are ultimately more likely to return.
SMS-oncology has conducted a growing number of global feasibilities, which include sites in Europe, North & South America, Asia and Australia. Our network of investigator sites is continuously expanding which yields more creative and strategic options for clinical conduct of studies.

SMS-oncology - Your Partner in Oncology Drug Development